In fact, a previous study performed by Vychytilova-Faltejskova et al. described that combining a serum-based four-miRNA panel and CEA levels yielded an increase in CRC detection of 47% compared to using the CEA marker alone [23]. Here, CEACAM5 is linked to colorectal carcinoma.